ADIPOQ and diabetes mellitus: Elevation of circulating adiponectin has shown effectiveness in preventing obesity and related cardiometabolic disorders; therefore, adiponectin is considered a therapeutic target for obesity, diabetes, and endothelial dysfunction [98].